IPO · MOLBIO

Molbio Diagnostics IPO listing gain & performance.

Issue price, subscription, listing day and what the share did after, from NSE data. Updated every evening.

· data for the trading session of Wed 18 Nov 2026

Issue price₹807.00₹768 to ₹807
Listing gain+21.4%at the opening price
Since the IPO+85.6%₹1,497.60 on 18 Nov
Subscribed70.3×times in total

Molbio Diagnostics IPO in brief

Written from NSE’s data, as of 18 Nov 2026.

Molbio Diagnostics came to the market at ₹807.00 a share (price band ₹768 to ₹807), with bidding open from 10 August to 12 August 2026. It listed on NSE on Monday, 17 August 2026, opening at ₹980.00, a gain of 21.4% on the issue price, and closed the first day +29.1% from the issue price after trading between +14.8% and +31.9%. 43% of the first day’s traded shares were taken for delivery.

The issue was subscribed 70.3× in total, institutions (QIB) 186×, HNIs (NII) 49.8×, retail investors 13.0×. Across the 91 IPOs subscribed 50× or more, the median listing gain was +26.6%.

Its listing gain beat 73% of the 227 main-board IPOs since October 2024, where the median was +7.6%. 3 months after listing it was +83.9% from the issue price and +42.5% from the first-day close, while NIFTY 50 moved +4.1% over the same days. Its highest price so far was 109% above the issue price (11 Sep 2026) and its lowest 15% above it (17 Aug 2026); it closed below the issue price on 0% of the days since listing.

Share price since listing

Daily closes, adjusted for later splits and bonuses. The dashed line is the IPO price.

IPO ₹80717 Aug 202618 Nov 2026₹1,498

Subscription

Times subscribed by investor group, NSE + BSE bids as reported by NSE.

Qualified institutions (QIB)186×
Non-institutional (NII / HNI)49.8×
NII, bids above ₹10 lakh50.8×
NII, ₹2–10 lakh47.8×
Retail investors13.0×
Employees13.3×
Total70.3×

For comparison, the median main-board IPO since Oct 2024 was subscribed 28.4× in total.

Listing day

Monday 17 August 2026.

Open+21.4%vs issue price
High / low+32% / +15%vs issue price
Close+29.1%vs issue price
Delivery43%₹1,586 Cr traded

Returns after listing

Against the issue price and the first-day close, with NIFTY 50 and the median IPO for comparison.

After listingFrom issue priceFrom first-day closeNIFTY 50Median IPO (from issue)
1 week24 Aug 2026+48.6%+15.1%-0.3%+8.0%
1 month16 Sep 2026+62.0%+25.5%-4.4%+9.4%
3 months17 Nov 2026+83.9%+42.5%+4.1%+10.3%

IPO details

From NSE’s issue page.

Company
Molbio Diagnostics
NSE symbol
MOLBIO
Board
Main board
Industry
Medical Equipment & Supplies
Bidding
10 Aug – 12 Aug 2026
Price band
₹768 to ₹807
Issue price
₹807.00
Issue size
Initial Public Offering comprising of Fresh Issue aggregating up to Rs. 2,000 million and Offer for Sale of up to 9,166,000 Equity Shares (including Employee reservation portion aggregating up to Rs. 15 million and Anchor Investor portion of up to 34,87,717 Equity Shares)
Bid lot
18 Equity Shares and in multiples thereof
Listing date
17 August 2026
ISIN
INE869T01028

How all IPOs did after listing →IPO calendar →

Questions

What was the listing gain of the Molbio Diagnostics IPO?
Molbio Diagnostics listed on 17 August 2026 and opened +21.4% against its issue price of ₹807.00; it closed the first day +29.1% from the issue price.
What is the Molbio Diagnostics share price now against the IPO price?
At the close of 18 November 2026, Molbio Diagnostics was at ₹1,497.60, +85.6% from the IPO price of ₹807.00.
How many times was the Molbio Diagnostics IPO subscribed?
Molbio Diagnostics’s IPO was subscribed 70.3× in total; QIB 186×; NII 49.8×; retail 13.0× (NSE + BSE bids, as reported by NSE).
When was the Molbio Diagnostics IPO open?
Bidding ran from 10 August to 12 August 2026 at a price band of ₹768 to ₹807; the shares listed on 17 August 2026.

From NSE’s issue list and daily price files (adjusted for later splits and bonuses), and subscription as NSE reports it (NSE + BSE bids). Past IPOs do not predict future ones. Information for learning, not investment advice; ChartMine is not a SEBI-registered adviser.

See it live on your chart.ChartMine for TradingView.